4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0001669396-16-000003
$BHCCIK 0000885590operating
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 3:40 PM ET
Size
5.3 KB
Accession
0001669396-16-000003
Insider Transaction Report
Form 4
Ross Thomas W. Sr.
Director
Transactions
- Purchase
Common Stock, no par value
2016-06-13$24.40/sh+4,000$97,600→ 21,882 total
Footnotes (2)
- [F1]Represents volume-weighted average price of purchases of 4,000 shares of common stock ('Shares') of Valeant Pharmaceuticals International, Inc. (the 'Company') at prices ranging from $24.37 to $24.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of Shares purchased by the reporting person at each separate price within the range set forth in this footnote.
- [F2]Represents number of Shares beneficially owned as of the filing date.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 3:40 PM ET
- Size
- 5.3 KB